Disease Correlation

Accurate heme derivative testing is crucial for diagnosis, monitoring, and management of these conditions

Liver Diseases

  • Hepatitis (Viral, Alcoholic, Drug-Induced)
  • Cirrhosis
  • Biliary Obstruction (Gallstones, Tumors)

Hepatitis (Viral, Alcoholic, Drug-Induced)

  • Laboratory Findings
    • Elevated Total Bilirubin: Typically > 1.0 mg/dL
    • Elevated Direct (Conjugated) Bilirubin: Increased proportion of direct bilirubin
    • Elevated Liver Enzymes: ALT and AST (indicators of liver inflammation/damage)
  • Disease State Correlation
    • Liver inflammation impairs bilirubin conjugation and excretion, leading to hyperbilirubinemia and elevated liver enzymes
    • Specific patterns of bilirubin and liver enzyme elevation can help differentiate between different types of hepatitis

Cirrhosis

  • Laboratory Findings
    • Elevated Total Bilirubin: Variable, may be normal in early stages
    • Elevated Direct (Conjugated) Bilirubin: Increased proportion of direct bilirubin
    • Elevated Liver Enzymes: Variable, may be normal or decreased in advanced stages
    • Decreased Albumin: Indicator of impaired liver synthetic function
    • Prolonged Prothrombin Time (PT): Indicator of impaired liver synthetic function
    • Thrombocytopenia: Low platelet count due to portal hypertension and splenomegaly
  • Disease State Correlation
    • Cirrhosis is characterized by chronic liver damage and scarring, leading to impaired bilirubin metabolism, decreased protein synthesis, and other complications
    • Elevated bilirubin, decreased albumin, and prolonged PT reflect the severity of liver dysfunction

Biliary Obstruction (Gallstones, Tumors)

  • Laboratory Findings
    • Elevated Total Bilirubin: Typically > 2.0 mg/dL
    • Elevated Direct (Conjugated) Bilirubin: Predominantly direct bilirubin
    • Elevated Alkaline Phosphatase (ALP) and Gamma-Glutamyl Transferase (GGT): Indicators of biliary obstruction
  • Disease State Correlation
    • Obstruction of the bile ducts prevents bilirubin excretion, leading to conjugated hyperbilirubinemia and elevated ALP and GGT

Hemolytic Anemias

  • Definition: Anemias caused by increased destruction of red blood cells
  • Examples: Hereditary spherocytosis, sickle cell anemia, autoimmune hemolytic anemia
  • Laboratory Findings * Elevated Total Bilirubin: Typically < 5.0 mg/dL * Elevated Indirect (Unconjugated) Bilirubin: Predominantly indirect bilirubin * Increased Reticulocyte Count: Indicates increased red blood cell production by the bone marrow * Decreased Hemoglobin and Hematocrit: Indicators of anemia * Increased Lactate Dehydrogenase (LDH): Released from damaged red blood cells * Decreased Haptoglobin: Binds free hemoglobin and is depleted in hemolytic anemia
  • Disease State Correlation
    • Increased red blood cell breakdown leads to elevated indirect bilirubin, increased reticulocyte count, and decreased hemoglobin

Porphyrias

  • Definition: A group of genetic disorders caused by deficiencies in enzymes of the heme synthesis pathway
  • Laboratory Findings
    • Elevated levels of specific porphyrins and porphyrin precursors in urine, blood, or feces
    • Specific patterns of porphyrin elevation depend on the type of porphyria
  • Acute Intermittent Porphyria (AIP): Elevated urine porphobilinogen (PBG) and delta-aminolevulinic acid (ALA) during acute attacks
  • Porphyria Cutanea Tarda (PCT): Elevated urine uroporphyrins
  • Disease State Correlation * Enzyme deficiencies in the heme synthesis pathway lead to the accumulation of specific porphyrins and porphyrin precursors, causing various symptoms

Iron Deficiency Anemia (IDA)

  • Definition: Anemia caused by insufficient iron levels, leading to impaired heme and hemoglobin synthesis
  • Laboratory Findings * Decreased Hemoglobin and Hematocrit: Indicators of anemia * Decreased Mean Corpuscular Volume (MCV): Microcytic anemia * Decreased Serum Iron: < 60 μg/dL (10.7 μmol/L) * Decreased Ferritin: < 20 ng/mL (women), < 20 ng/mL (men) * Increased Total Iron-Binding Capacity (TIBC): > 450 μg/dL (80.6 μmol/L) * Decreased Transferrin Saturation: < 20%
  • Disease State Correlation
    • Inadequate iron stores impair heme and hemoglobin synthesis, leading to microcytic anemia and decreased iron levels

Hemochromatosis

  • Definition: A genetic disorder characterized by excessive iron absorption and accumulation in tissues
  • Laboratory Findings * Elevated Serum Iron: > 170 μg/dL (30.4 μmol/L) * Elevated Transferrin Saturation: > 50% * Elevated Ferritin: > 200 ng/mL (women), > 500 ng/mL (men) * Decreased Total Iron-Binding Capacity (TIBC): < 240 μg/dL (42.9 μmol/L)
  • Disease State Correlation
    • Excessive iron absorption leads to iron overload, causing tissue damage and organ dysfunction

Lead Poisoning

  • Definition: Exposure to lead, which inhibits enzymes in the heme synthesis pathway
  • Laboratory Findings * Elevated Blood Lead Levels: > 5 μg/dL * Elevated Zinc Protoporphyrin (ZPP) in Red Blood Cells: Indicates impaired heme synthesis * Decreased Hemoglobin: Anemia
  • Disease State Correlation
    • Lead inhibits ALA dehydratase and ferrochelatase, disrupting heme synthesis and causing neurological and developmental problems

Anemia of Chronic Disease (ACD)

  • Definition: Anemia associated with chronic inflammatory conditions
  • Laboratory Findings * Decreased Hemoglobin and Hematocrit: Indicators of anemia * Decreased Serum Iron: < 60 μg/dL (10.7 μmol/L) * Decreased Total Iron-Binding Capacity (TIBC): < 240 μg/dL (42.9 μmol/L) * Decreased Transferrin Saturation: < 20% * Normal or Increased Ferritin: > 20 ng/mL (women), > 20 ng/mL (men)
  • Disease State Correlation
    • Inflammation leads to increased hepcidin production, which reduces iron absorption and release, causing anemia

Summary Table of Key Findings

Condition Total Bilirubin Direct Bilirubin Indirect Bilirubin ALT/AST ALP/GGT Serum Iron Ferritin TIBC Transferrin Saturation
Hepatitis N N N N
Cirrhosis ↑/↓ N/↑ N N/↑ N/↑
Biliary Obstruction ↑↑ N N ↑↑ N N N N
Hemolytic Anemia N ↑↑ N N
Iron Deficiency Anemia N N N N N
Hemochromatosis N N N N ↑↑ ↑↑ ↑↑
Anemia of Chronic Disease N N N N N N/↑
  • ↑ = Increased, ↓ = Decreased, N = Normal, ↑↑ = Significantly increased, N/↑ = Normal or Increased, N/↓ = Normal or Decreased

Key Terms

  • Bilirubin: A yellow pigment produced from the breakdown of heme
  • Liver Enzymes: ALT (alanine aminotransferase) and AST (aspartate aminotransferase)
  • Hemolytic Anemia: Anemia caused by increased destruction of red blood cells
  • Porphyria: A genetic disorder caused by deficiencies in enzymes of the heme synthesis pathway
  • Iron Deficiency Anemia (IDA): Anemia caused by insufficient iron levels
  • Hemochromatosis: A genetic disorder characterized by excessive iron absorption and accumulation in tissues
  • Lead Poisoning: Exposure to lead, which inhibits enzymes in the heme synthesis pathway
  • Anemia of Chronic Disease (ACD): Anemia associated with chronic inflammatory conditions
  • MCV: Mean Corpuscular Volume, a measure of red blood cell size
  • Ferritin: A protein that stores iron
  • Total Iron-Binding Capacity (TIBC): A measure of the blood’s capacity to bind iron
  • Transferrin Saturation: The percentage of transferrin that is bound to iron
  • Porphyrins: Intermediates in heme synthesis